Treating left main coronary artery disease with percutaneous coronary intervention lowers the risk of severe cardiovascular events after weeks of surgery.
Surprising Trends Found in Cause of Long-Term Death After Percutaneous Coronary Intervention
More people with known coronary heart disease die because of other conditions like cancer, lung and neurological diseases, rather than heart disease as compared to 20 years ago, reveals a Mayo Study.
More people with known coronary heart disease die because of other conditions like cancer, lung and neurological diseases, rather than heart disease as compared to 20 years ago, reveals a Mayo Study.
‘Percutaneous coronary intervention is better than coronary artery bypass grafting in reducing the risk of severe cardiovascular events.’
The finding is significant when it comes to selecting the form of treatment: percutaneous coronary intervention is less burdensome on the patient, as it does not require long-term hospitalisation and enables rapid return to work. The prognosis of left main coronary artery disease is worse than in any other form of coronary artery disease. The treatment options include percutaneous coronary intervention and coronary artery bypass grafting.
In European and American treatment guidelines, coronary artery bypass grafting is generally regarded as the first-line treatment for severe left main coronary artery disease. However, some studies have suggested that percutaneous coronary intervention with drug-releasing stent implantation would also be a recommendable course of treatment in the severe form of the disease, but the evidence has been inconsistent.
Systolic Blood Pressure is a Useful Predictor for Patients Experiencing STEMI
STEMI is one type of myocardial infarction in which a part the heart muscle (myocardium) has died due to the obstruction of blood supply to the area.
STEMI is one type of myocardial infarction in which a part the heart muscle (myocardium) has died due to the obstruction of blood supply to the area.
The authors pooled evidence from six comparable, randomised, controlled trials involving 4,700 people.
Advertisements
Aspirin may Influence Heart Problems After Normal Surgery
Previous stent or angioplasty patients can experience heart problems after a normal surgery with peri-operative aspirin therapy
Previous stent or angioplasty patients can experience heart problems after a normal surgery with peri-operative aspirin therapy
There were no differences between the treatments as regards the risk of death, or cardiac or cerebrovascular events. Percutaneous coronary intervention patients needed repetitive interventions more often over the years.
Advertisements
New ESC Guidelines Help Treat STEMI Patients
New guidelines published provide a clear definition of when to start the clock for the 90 minute target to treat patients with percutaneous coronary intervention (PCI).
New guidelines published provide a clear definition of when to start the clock for the 90 minute target to treat patients with percutaneous coronary intervention (PCI).
There are no differences in mortality between patients of percutaneous coronary intervention and patients undergoing coronary artery bypass grafting, and as percutaneous coronary intervention is less burdensome on the patient both from the viewpoint of quality of life and functional capacity, it is an option worth considering.
Source-Eurekalert
